Listed by the USPTO as BELYAVSKYI, MICHAIL A
Tech Center 1600 • Art Units: 1641 1643 1644 1646 1647 1653 1654
This examiner grants 64% of resolved cases
BELYAVSKYI, Michail A has resolved 1120 cases in Tech Center 1600 and records a 63.9% allowance rate. The 28.0% interview lift indicates that examiner interviews can provide substantial support for favorable prosecution outcomes. The median time to allowance is 1150 days, so applicants should integrate interview preparation with a plan for sustained claim development.
Genentech Inc., The Regents of the University of California, and City of Hope are the leading companies. NORTON ROSE FULBRIGHT US LLP, Knobbe, Martens, Olson & Bear, LLP, and BOZICEVIC, FIELD & FRANCIS LLP are the leading firms. For art unit 1641, counsel should connect technical explanations directly to the written record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18020611 | TARGETED PROTEIN DEGRADATION IN THERAPEUTIC CELLS | Non-Final OA | The Regents of the University of California |
| 17863149 | METHODS FOR TREATING VIRAL INFECTIONS | Non-Final OA | The Regents of The University of California |
| 17800387 | CAR T CELLS TARGETING THE INTEGRIN ALPHAV BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES | Final Rejection | University of Virginia Patent Foundation |
| 18656496 | METHOD FOR PRODUCING CD8alpha+beta+ CYTOTOXIC T CELLS | Non-Final OA | KYOTO UNIVERSITY |
| 18603451 | AUGMENTATION OF FIBROBLAST REGENERATIVE ACTIVITY | Non-Final OA | FIGENE, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy63.9% of resolved applications examined by Michail A Belyavskyi were allowed (1,120 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.
This examiner's interview lift is +28.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Michail A Belyavskyi took 1,150 days on average from filing to allowance.
Michail A Belyavskyi examines applications in Art Unit 1641 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
